Cargando…

Raised CD40L expression attenuates drug resistance in Adriamycin-resistant THP-1 cells

Acute myeloid leukemia is a common hematological malignancy that often exhibits strong drug resistance when treated using conventional chemotherapy. Although numerous studies have been carried out to develop methods of overcoming drug resistance, the results have generally been unsatisfactory. CD40...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Zhongxin, Chen, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027340/ https://www.ncbi.nlm.nih.gov/pubmed/32104283 http://dx.doi.org/10.3892/etm.2020.8452

Ejemplares similares

CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway
por: Feng, Zhongxin, et al.
Publicado: (2019)

Expression of 85‐kDa Protein of Adriamycin‐resistant Tumor Cells during Hematopoietic Differentiation of THP‐1 and HEL Cells
por: Ishii, Shigetaka, et al.
Publicado: (1992)

Shock Wave and THP‐Adriamycin for Treatment of Rabbit's Bladder Cancer
por: Hoshi, Senji, et al.
Publicado: (1992)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
por: Qi, Min, et al.
Publicado: (2021)

YB-1 Expression Is Associated with Lymph Node Metastasis and Drug Resistance to Adriamycin in Breast Cancer
por: Dong, Hanzhi, et al.
Publicado: (2023)

CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway [Corrigendum]
por: Feng, Z, et al.
Publicado: (2019)

Downregulation of CD40L–CD40 attenuates seizure susceptibility and severity of seizures
por: Pototskiy, Esther, et al.
Publicado: (2021)

Solanum nigrum Unripe fruit fraction attenuates Adriamycin resistance by down-regulating multi-drug resistance protein (Mdr)-1 through Jak-STAT pathway
por: Jagadeeshan, Sankar, et al.
Publicado: (2017)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Author Correction: Downregulation of CD40L–CD40 attenuates seizure susceptibility and severity of seizures
por: Pototskiy, Esther, et al.
Publicado: (2021)

Different Induction of PD-L1 (CD274) and PD-1 (CD279) Expression in THP-1-Differentiated Types 1 and 2 Macrophages
por: Lai, Chun-Yi, et al.
Publicado: (2021)

The Effect of Talaromyces marneffei Infection on CD86 Expression in THP-1 Cells
por: Yang, Di, et al.
Publicado: (2021)

Downregulation of hypermethylated in cancer-1 by miR-4532 promotes adriamycin resistance in breast cancer cells
por: Feng, Fan, et al.
Publicado: (2018)

TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line
por: Manh Hung, Le Van, et al.
Publicado: (2018)

Acute Induction of Adriamycin‐resistance in Human Colon Carcinoma HT‐29 Cells Exposed to a Sublethal Dose of Adriamycin
por: Tomida, Akihiro, et al.
Publicado: (1995)

Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
por: Allen, Barrett D., et al.
Publicado: (2019)

Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines.
por: Snow, K., et al.
Publicado: (1991)

Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells
por: Sun, Wenxia, et al.
Publicado: (2013)

CD40/CD40L expression and its prognostic value in cervical cancer
por: Grazia, G.A., et al.
Publicado: (2023)

CXXC5 Attenuates Pulmonary Fibrosis in a Bleomycin-Induced Mouse Model and MLFs by Suppression of the CD40/CD40L Pathway
por: Cheng, Wei, et al.
Publicado: (2020)

Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.
por: Nishio, K., et al.
Publicado: (1990)

CD40–CD40L in Neurological Disease
por: Ots, Heather D., et al.
Publicado: (2022)

MicroRNA-16 sensitizes drug-resistant breast cancer cells to Adriamycin by targeting Wip1 and Bcl-2
por: Gao, Xitao, et al.
Publicado: (2019)

Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance?
por: Kones, Richard, et al.
Publicado: (2013)

Expression of CD40 and CD40L in Gastric Cancer Tissue and Its Clinical Significance
por: Li, Rui, et al.
Publicado: (2009)

Expression of CD40, CD40L and IgM production in patients with ataxia-telangiectasia
por: Pereira, Camila Teles Machado, et al.
Publicado: (2015)

Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells
por: Cao, Bei, et al.
Publicado: (2013)

Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells
por: XIE, XIAO-HONG, et al.
Publicado: (2014)

Paeoniflorin Attenuated TREM-1-Mediated Inflammation in THP-1 Cells
por: Cao, Li, et al.
Publicado: (2022)

Soluble CD40 ligand inhibits the growth of non-Hodgkin's lymphoma cells through the JNK signaling pathway
por: Feng, Zhongxin, et al.
Publicado: (2021)

Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line.
por: Twentyman, P. R., et al.
Publicado: (1987)

NBDHEX re‐sensitizes adriamycin‐resistant breast cancer by inhibiting glutathione S‐transferase pi
por: Sha, Huanhuan, et al.
Publicado: (2022)

Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells
por: Chen, Wei-xian, et al.
Publicado: (2018)

CD40 is Positively Correlated with the Expression of Nucleophosmin in Cisplatin-Resistant Bladder Cancer
por: Luo, Chenshuo, et al.
Publicado: (2020)

Preeclampsia serum upregulates CD40/CD40L expression and induces apoptosis in human umbilical cord endothelial cells
por: Wu, Chun-feng, et al.
Publicado: (2012)

Reversal of Tumor Necrosis Factor Resistance in Tumor Cells by Adriamycin via Suppression of Intracellular Resistance Factors
por: Watanabe, Naoki, et al.
Publicado: (1995)

Spotlight on drug-resistant Shigella: raising awareness within general practice
por: Charles, Hannah, et al.
Publicado: (2023)

Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy
por: Shin, Chang-Ae, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hbm6fq5c0bdp969d6i96kmvsd7